Abstract
COVID-19 pandemic has been a problem worldwide. It is important to identify people at risk of progressing to severe complications and to investigate if some existing antivirals could have any action against SARS-CoV-2. In this context, HIV-infected individuals and antiretroviral drugs might be included, respectively. Herein we present the case of a 63-year-old HIV-infected woman with undetectable viral load, on dolutegravir, tenofovir and lamivudine, who was hospitalized due to COVID-19 pneumonia. In spite of having some clinical markers of severity on admission, the patient improved and was discharged after a week. To our knowledge, this is the first report of severe SARS-CoV-2 infection in an HIV-infected individual in Brazil.
【저자키워드】 COVID-19, SARS-CoV-2, HIV, AIDS, 【초록키워드】 Brazil, Hospitalized, Antiviral, Pneumonia, knowledge, COVID-19 pandemic, severity, Infection, risk, Viral load, Admission, individual, antiretroviral drug, severe SARS-CoV-2, identify, the patient, discharged, severe complication, clinical marker, undetectable, 【제목키워드】 Brazil, Pneumonia, Viral load, Antiretroviral therapy, Porto, undetectable,